Brazil has consistently appeared in the top 10 global pharmaceutical markets over the last decade and is making steady progress.

The first-time launch landscape is growing. In an increasing number of cases, it’s emerging biopharma and biotech companies launching new drugs rather than established pharma giants leading the way.

Reverse mentoring challenges the status quo and flips traditional learning dynamics on their axis. This how-to guide deconstructs what must be considered when building a reverse mentoring scheme in pharma.

How can emergency measures be translated into permanent solutions to increase the power and number of these trials?

A highly-effective pharmacovigilance function is a rising value differentiator for pharmaceutical companies. Read to find out more about the challenges.

The pharmaceutical industry views itself as increasingly patient centric, but do two patient advocates agree? In this roundtable discussion, they consider what the industry is doing well, and their views on how it could improve further

John Wahba, Medical Head of the Global Digital Hub, GSK, talks about how collaboration and teamwork will drive change in pharma, his views on digital and omnichannel optimisation and his passion for patient empowerment

The ambition of the Healthcare Businesswomen’s Association is to drive change in diversity, equity and inclusion healthcare and life sciences. Read the article to find out how.